The Congenital Heart Institute of Florida, All Children's Hospital, Saint Petersburg, Florida, USA.
Ann Thorac Surg. 2011 Apr;91(4):1248-54; discussion 1254-5. doi: 10.1016/j.athoracsur.2010.10.083.
This manuscript reviews all patients who underwent orthotopic heart transplantations (OHT) at our program (116 patients underwent 119 OHT) to describe their diagnostic characteristics and to assess risk factors for mortality.
Median age at OHT was 179 days (mean, 1,446.6 ± 188.9 days [4.0 ± 0.5 years]; range, 5 days to 7,125 days [19.5 years]; 15 neonates, 68 infants). Median weight at OHT was 5.5 kg (mean, 17.2 ± 2.1 kg; range, 2.2 to 113 kg). Diagnoses were cardiomyopathy (n = 37), primary transplantation for hypoplastic left heart syndrome (HLHS) or HLHS-related malformation (n = 29), transplantation after prior cardiac surgery for HLHS or HLHS-related malformation (n = 9), non-HLHS congenital heart disease (n = 39), and retransplant (n = 5).
Overall Kaplan-Meier 5-year survival was 72.7%. Operative mortality was 12.6% (15 patients). Late mortality was 13.4% (16 patients). Eighty-five patients survived, with a mean follow-up of 5.76 ± 0.48 years (median, 5.1 years; range, 0.12 to 14.0 years). Total follow-up was 507.0 years. No survival difference was seen among the five diagnostic subgroups (p = 0.20). Univariate association between risk factors and survival was assessed for the following variables: age (p = 0.91), weight (p = 0.86), sex (p = 0.47), race (p = 0.40), insurance classification (p = 0.42), high PRA (p = 0.20), pretransplant mechanical circulatory support (p < 0.001), posttransplant mechanical circulatory support (p < 0.001), redo sternotomy (p = 0.07), heterotaxy (p = 0.02), cardiopulmonary bypass time (p = 0.01), and donor heart cross-clamp time (p = 0.02).
Excellent results are expected for children undergoing OHT regardless of diagnostic classification. Pretransplant mechanical circulatory support, posttransplant mechanical circulatory support, cardiopulmonary bypass time, donor heart cross-clamp time, and heterotaxy are risk factors for decreased survival.
本研究回顾了在我们中心接受原位心脏移植(OHT)的所有患者(116 例患者接受了 119 例 OHT),以描述其诊断特征并评估死亡率的危险因素。
OHT 时的中位年龄为 179 天(均值为 1446.6±188.9 天[4.0±0.5 岁];范围为 5 天至 7125 天[19.5 岁];15 例新生儿,68 例婴儿)。OHT 时的中位体重为 5.5kg(均值为 17.2±2.1kg;范围为 2.2 至 113kg)。诊断包括心肌病(n=37)、左心发育不全综合征(HLHS)或 HLHS 相关畸形的初次移植(n=29)、HLHS 或 HLHS 相关畸形的心脏手术后移植(n=9)、非 HLHS 先天性心脏病(n=39)和再次移植(n=5)。
总体 Kaplan-Meier 5 年生存率为 72.7%。手术死亡率为 12.6%(15 例)。晚期死亡率为 13.4%(16 例)。85 例患者存活,平均随访 5.76±0.48 年(中位数为 5.1 年;范围为 0.12 至 14.0 年)。总随访时间为 507.0 年。五个诊断亚组之间的生存差异无统计学意义(p=0.20)。评估了以下变量与生存的单因素关联:年龄(p=0.91)、体重(p=0.86)、性别(p=0.47)、种族(p=0.40)、保险分类(p=0.42)、高 PRA(p=0.20)、移植前机械循环支持(p<0.001)、移植后机械循环支持(p<0.001)、再次开胸(p=0.07)、心脏异位(p=0.02)、体外循环时间(p=0.01)和供心阻断时间(p=0.02)。
无论诊断分类如何,接受 OHT 的儿童都有望获得优异的结果。移植前机械循环支持、移植后机械循环支持、体外循环时间、供心阻断时间和心脏异位是降低生存率的危险因素。